- Home
- DSP vs WHWK Comparison
DSP vs WHWK Comparison
Compare DSP & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSP | WHWK |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | 23 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.9M | 233.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | DSP | WHWK |
|---|---|---|
| Price | $13.18 | $3.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $17.81 | $7.50 |
| AVG Volume (30 Days) | 288.4K | ★ 653.2K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $344,201,000.00 | N/A |
| Revenue This Year | $20.27 | N/A |
| Revenue Next Year | $16.88 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $8.11 | $1.57 |
| 52 Week High | $15.18 | $5.50 |
Technical Indicators
Market Signals| Indicator | DSP | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 61.40 | 43.85 |
| Support Level | $10.77 | $3.85 |
| Resistance Level | $13.89 | $4.38 |
| Average True Range (ATR) | 0.75 | 0.38 |
| MACD | 0.13 | -0.05 |
| Stochastic Oscillator | 88.78 | 20.35 |
Price Performance
Historical ComparisonAbout DSP Viant Technology Inc.
Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.